ANIXA BIOSCIENCES, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2024-10-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2024-07-31 was $159.00K, a 835.29% increase year-over-year.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2024-04-30 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2024-01-31 was $96.00K, a 284.00% increase year-over-year.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2024 was $255.00K, a 177.17% increase from fiscal 2023.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2023 was $92.00K, a 5.15% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2022 was $97.00K.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2018 was $15.00K, a 53.73% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2024-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $255.00K 10-K · filed 2026-01-12 |
| 2024-07-31 | $159.00K 10-Q · filed 2025-09-10 | $280.00K derived: sum of 4 quarters · filed 2025-09-10 |
| 2024-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | $138.00K derived: sum of 4 quarters · filed 2025-05-28 |
| 2024-01-31 | $96.00K 10-Q · filed 2025-03-11 | $163.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-10-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $92.00K 10-K · filed 2025-01-10 |
| 2023-07-31 | $17.00K 10-Q · filed 2024-09-06 | $92.00K derived: sum of 4 quarters · filed 2024-09-06 |
| 2023-04-30 | $25.00K 10-Q · filed 2024-06-04 | $83.00K derived: sum of 4 quarters · filed 2024-06-04 |
| 2023-01-31 | $25.00K 10-Q · filed 2024-03-12 | $122.00K derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-10-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $97.00K 10-K · filed 2024-01-16 |
| 2022-07-31 | $8.00K 10-Q · filed 2023-09-06 | |
| 2022-04-30 | $64.00K 10-Q · filed 2023-06-14 | |
| 2021-07-31 | $139.00K 10-Q · filed 2022-09-09 | |
| 2018-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $15.00K 10-K · filed 2020-01-09 |
| 2018-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06 | $29.61K derived: sum of 4 quarters · filed 2019-09-06 |
| 2018-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12 | $29.61K derived: sum of 4 quarters · filed 2019-06-12 |
| 2018-01-31 | $15.00K 10-Q · filed 2018-03-09 | $29.61K derived: sum of 4 quarters · filed 2019-01-11 |
| 2017-10-31 | $14.61K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $32.42K 10-K · filed 2019-01-11 |
| 2017-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $21.18K derived: sum of 4 quarters · filed 2018-01-09 |
| 2017-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26 | $37.81K derived: sum of 4 quarters · filed 2018-01-09 |
| 2017-01-31 | $17.81K 10-Q · filed 2017-03-16 | $42.81K derived: sum of 4 quarters · filed 2018-01-09 |
| 2016-10-31 | $3.36K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $31.36K 10-K · filed 2018-01-09 |
| 2016-07-31 | $16.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | $28.00K derived: sum of 4 quarters · filed 2016-12-08 |
| 2016-04-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | $51.36K derived: sum of 4 quarters · filed 2016-12-08 |
| 2016-01-31 | $6.36K 10-Q · filed 2016-02-19 | $48.46K derived: sum of 4 quarters · filed 2016-12-08 |
| 2015-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $46.10K 10-K · filed 2016-12-08 |
| 2015-07-31 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $90.05K derived: sum of 4 quarters · filed 2015-12-23 |
| 2015-04-30 | $2.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $55.65K derived: sum of 4 quarters · filed 2015-12-23 |
| 2015-01-31 | $4.00K 10-Q · filed 2015-03-09 | |
| 2014-10-31 | $43.95K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $84.70K 10-K · filed 2015-12-23 |
| 2014-07-31 | $5.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | |
| 2013-10-31 | $304.69K 10-K · filed 2015-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |